Nevertheless, C3 consistently shows up in biomarker studies in association with HAND and AD neuropathogenesis, suggesting it may be useful as a therapeutic target or, when coupled with other biomarkers, a readout to determine therapeutic strategies and disease progression. Here, C3 is linked to Alzheimer disease.